Información del artículo
El Texto completo está disponible en PDF
Bibliografía Seleccionada
[Brittenham, 2000]
G. Brittenham.
“Disorders of Iron Metabolism: Iron Deficiency and Overload,” in Hematology: Basic Principles and Practice, 3rd,
[Hagege et al., 2001]
I. Hagege, et al.
Long-Term Administration of High-Dose Deferoxamine 2 Days per Week in Thalassemic Patients.
European Journal of Haematology, 67 (2001), pp. 230-231
[Kattamis et al., 2001]
A. Kattamis, et al.
Variations of Ferritin Levels over a Period of 15 Years as a Compliance Chelation Index in Thalassemic Patients.
American Journal of Hematology, 68 (2001), pp. 221-224
[Lucarelli et al., 2001]
G. Lucarelli, et al.
The Cure of the Thalassemia with Bone Marrow Transplantation.
Bone Marrow Transplantation, 28 (2001), pp. S11-S13
[Schrier, 2002]
S. Schrier.
Pathophysiology of Thalassemia.
Current Opinion in Hematology, 9 (2002), pp. 123-126
[Tiosano and Hochberg, 2001]
D. Tiosano, Z. Hochberg.
Endocrine Complications of Thalassemia.
Journal of Endocrinological Investigation, 24 (2001), pp. 716-723
Copyright © 2005. Lippincott Williams & Wilkins